CHE CHEMED CORP
Services-Home Health Care Services · NYSE · SEC CIK 19584 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.2%
TTM net income YoY1.3%
TTM EPS YoY10.5%
Revenue 3-yr CAGR6.1%
Net income 3-yr CAGR4.9%
Margins
Gross margin33.6%
Operating margin13.9%
Net margin10.6%
FCF margin11.1%
EBITDA margin16.3%
Returns
ROE29.1%
ROA16.9%
ROIC (approx.)27.4%
Asset turnover1.59x
Leverage & solvency
Liabilities / assets49.9%
Debt / equity0.27x
Current ratio1.11x
Interest coverage75.39x
Cash quality & payout
Operating cash flow / net income1.29x
Accruals ratio-4.8%
Payout ratio11.9%
Capex / revenue2.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $690.94M | $673.25M | $657.51M | $639.34M | $624.90M | $618.80M | $646.94M | $639.99M |
| Cost of revenue | $457.98M | $451.78M | $441.75M | $414.17M | $425.14M | $434.11M | $430.53M | $405.88M |
| Gross profit | $232.96M | $221.47M | $215.76M | $225.17M | $199.76M | $184.69M | $216.41M | $234.12M |
| SG&A expense | $111.47M | $115.20M | $114.32M | $105.50M | $105.78M | $100.32M | $105.59M | $104.25M |
| Operating income | $96.42M | $89.20M | $84.58M | $100.65M | $74.75M | $68.08M | $94.76M | $113.88M |
| Interest expense | $2.10M | $1.79M | $512,000 | $521,000 | $457,000 | $443,000 | $329,000 | $499,000 |
| Pretax income | $96.71M | $91.33M | $88.84M | $105.44M | $83.54M | $71.11M | $95.67M | $120.12M |
| Income tax | $25.06M | $23.63M | $22.54M | $28.69M | $19.31M | $18.62M | $23.92M | $29.80M |
| Net income | $71.65M | $67.70M | $66.30M | $76.75M | $64.24M | $52.49M | $71.76M | $90.32M |
| EBITDA | $110.85M | $103.47M | $101.45M | $116.98M | $88.41M | $81.77M | $110.78M | $129.71M |
| EPS (basic) | 5.49 | 5.14 | 4.85 | — | 4.46 | 3.60 | 4.91 | — |
| EPS (diluted) | 5.45 | 5.13 | 4.84 | — | 4.46 | 3.57 | 4.86 | — |
| Dividends declared per share | 0.70 | 0.60 | 0.60 | 0.60 | 0.60 | 0.50 | 0.50 | 0.50 |
| Weighted avg. shares (diluted) | 13.13M | 13.20M | 13.69M | — | 14.41M | 14.70M | 14.76M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $48.43M | $40.22M | $16.86M | $74.52M | $129.75M | $249.90M | $173.88M | $178.35M |
| Receivables | $254.86M | $188.63M | $215.48M | $182.57M | $215.57M | $184.88M | $285.87M | $171.16M |
| Inventory | $7.75M | $7.63M | $7.21M | $7.54M | $8.24M | $9.15M | $7.79M | $8.19M |
| Current assets | $365.73M | $291.24M | $274.06M | $302.62M | $395.24M | $491.38M | $502.38M | $394.75M |
| PP&E, net | $216.96M | $208.50M | $207.73M | $205.66M | $203.94M | $202.28M | $199.68M | $200.84M |
| Goodwill | $754.76M | $667.00M | $667.00M | $667.00M | $666.99M | $667.00M | $666.94M | $666.74M |
| Intangibles | $78.79M | $78.60M | $80.42M | $82.76M | $84.93M | $87.36M | $89.93M | $92.21M |
| Total assets | $1.72B | $1.58B | $1.54B | $1.54B | $1.62B | $1.72B | $1.73B | $1.67B |
| Current liabilities | $330.93M | $319.85M | $321.42M | $287.13M | $292.04M | $263.89M | $290.56M | $285.69M |
| Long-term debt | $236.00M | $140.00M | $91.20M | — | — | — | — | — |
| Total debt | $236.00M | $140.00M | $91.20M | — | — | — | — | — |
| Total liabilities | $857.02M | $749.08M | $687.82M | $558.78M | $546.94M | $519.36M | $544.75M | $549.58M |
| Shareholders' equity | $861.42M | $830.51M | $847.99M | $979.40M | $1.08B | $1.20B | $1.18B | $1.12B |
| Net debt | $187.57M | $99.78M | $74.34M | — | — | — | — | — |
| Cash flow statement | ||||||||
| Operating cash flow | $56.59M | $84.81M | $88.22M | $133.53M | $83.39M | $138.61M | $32.74M | $164.91M |
| Capital expenditure | $18.72M | $15.52M | $17.12M | $16.35M | $17.50M | $15.81M | $13.28M | $12.76M |
| Free cash flow | $37.87M | $69.29M | $71.10M | $117.19M | $65.89M | $122.80M | $19.46M | $152.15M |
| Investing cash flow | -$81.39M | -$28.24M | -$37.79M | -$15.95M | -$14.23M | -$15.48M | -$13.67M | -$12.52M |
| Financing cash flow | $33.01M | -$33.21M | -$108.09M | -$172.82M | -$189.31M | -$47.10M | -$23.54M | -$212.49M |
| Depreciation & amortization | $14.43M | $14.27M | $16.87M | $16.33M | $13.66M | $13.69M | $16.02M | $15.83M |
| Dividends paid | $9.19M | $7.88M | $8.17M | $8.50M | $8.65M | $7.22M | $7.33M | $7.50M |
| Share buybacks | $62.52M | $97.48M | $190.04M | $174.56M | $180.78M | $42.95M | $33.22M | $209.34M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.